(Wired) – With a new product called RateRx, Ron Gutman, CEO of the digital health startup HealthTap, aims to take on this lack of transparency. RateRx will let doctors from all over the world rate the effectiveness of certain medications for certain ailments. They’ll also be able to leave comments about those drugs and rate other doctors’ answers. From that data, patients will be able to surface the best answers to make informed choices about the drugs they take.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.